» Articles » PMID: 38511058

Inhibition of Breast Cancer Cell Growth and Migration Through SiRNA-mediated Modulation of Circ_0009910/miR-145-5p/MUC1 Axis

Overview
Date 2024 Mar 21
PMID 38511058
Authors
Affiliations
Soon will be listed here.
Abstract

Circular RNAs (circRNAs) characterize a novel kind of regulatory RNAs distinguished by great evolutionary conservation and constancy. Although their exact role in malignancies is not fully understood, they mainly work through specific axes. Circular RNA/miRNA/mRNA axes affect the pathogenesis of human cancers including breast cancer. We assessed the expression and function of circ_0009910/miR-145-5p/MUC1 axis in Breast Cancer tissues and MCF-7 cells. Expression levels of circ_0009910 and MUC1 were notably increased in breast cancer tissues compared with control tissues, parallel with the down-regulation of miR-145-5p. Clinicopathological analysis indicated that up-regulation of circ_0009910 in breast tumors is related to invasion of the tumor to lymph node (P value = 0.011). Also, the downregulation of miR-145-5p was significantly correlated with tumor invasion to lymph nodes (P value = 0.04) and HER2-negative tumors (P value = 0.037). Finally, overexpression of MUC1 was correlated with age under 45 years (P value = 0.002). More importantly, circ_0009910-siRNA decreased the proliferation and migration ability of breast cancer cells, enhanced expression of miR-145-5p, and decreased levels of MUC1. Taken together, the circ_0009910/miR-145-5p/MUC1 axis has been demonstrated to affect the pathogenesis of breast cancer and might provide a target for breast cancer treatment.

Citing Articles

Role of miRNA‑145‑5p in cancer (Review).

Chen Z, Qin Y Oncol Rep. 2025; 53(3).

PMID: 39886965 PMC: 11800069. DOI: 10.3892/or.2025.8872.


Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications.

Benacka R, Szaboova D, Gulasova Z, Hertelyova Z Int J Mol Sci. 2025; 26(1.

PMID: 39795985 PMC: 11719911. DOI: 10.3390/ijms26010127.


Unraveling non-coding RNAs in breast cancer: mechanistic insights and therapeutic potential.

Shaikh M, Doshi G Med Oncol. 2024; 42(1):37.

PMID: 39730979 DOI: 10.1007/s12032-024-02589-x.


Importance of LINC00852/miR-145-5p in breast cancer: a bioinformatics and experimental study.

Shakoori A, Hosseinzadeh A, Nafisi N, Omranipour R, Sahebi L, Nazanin Hosseinkhan Discov Oncol. 2024; 15(1):672.

PMID: 39557729 PMC: 11574217. DOI: 10.1007/s12672-024-01553-5.

References
1.
Ye P, Shi Y, An N, Zhou Q, Guo J, Long X . miR-145 overexpression triggers alteration of the whole transcriptome and inhibits breast cancer development. Biomed Pharmacother. 2018; 100:72-82. DOI: 10.1016/j.biopha.2018.01.167. View

2.
Kadkhoda S, Taslimi R, Noorbakhsh F, Darbeheshti F, Tavakkoly Bazzaz J, Ghafouri-Fard S . Importance of Circ0009910 in colorectal cancer pathogenesis as a possible regulator of miR-145 and PEAK1. World J Surg Oncol. 2021; 19(1):265. PMC: 8417957. DOI: 10.1186/s12957-021-02378-0. View

3.
Cao L, Wang M, Dong Y, Xu B, Chen J, Ding Y . Circular RNA circRNF20 promotes breast cancer tumorigenesis and Warburg effect through miR-487a/HIF-1α/HK2. Cell Death Dis. 2020; 11(2):145. PMC: 7039970. DOI: 10.1038/s41419-020-2336-0. View

4.
Hosseinzadeh A, Merikhian P, Naseri N, Eisavand M, Farahmand L . MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy. Cancer Cell Int. 2022; 22(1):110. PMC: 8897942. DOI: 10.1186/s12935-022-02523-z. View

5.
Li Y, Lin S, An N . Hsa_circ_0009910: oncogenic circular RNA targets microRNA-145 in ovarian cancer cells. Cell Cycle. 2020; 19(15):1857-1868. PMC: 7469526. DOI: 10.1080/15384101.2020.1731650. View